Symptoms and medication scores results in the ALUMITES study, a randomised, controlled, multicenter phase IV study with house dust mites subcutaneous immunotherapy for allergic rhinitis. Six months interim analysis
Data de publicación
2013Título da revista
Allergy
Tipo de contido
Publicación de congreso